PERSPECTIVE THERAPEUTICS, INC. (CATX) valuation

Share price $4.17 · As of last filing 2026-03-31

Price-to-Earnings

P/E · Trailing Diluted

-2.98×

P/E history →

Price-to-Free-Cash-Flow

P/FCF · Trailing

-4.43×

P/FCF history →

Free-Cash-Flow Yield

FCF Yield · Trailing

-22.57%

FCF Yield history →

Enterprise-Value-to-EBITDA

EV/EBITDA · Trailing

-1.80×

EV/EBITDA history →

Price-to-Sales

P/S · Trailing

—

P/S history →

Price-to-Book

P/B · Latest filing

1.37×

P/B history →

Special situation detected — historical normalisation may not reflect go-forward economics. EPV and Reverse-DCF outputs below are anchored on history that no longer represents the entity going forward (net cash > 50% of market cap) . Inspect the balance sheet, recent 8-K filings, and the cards above before relying on these models.

net cash > 50% of market cap. Net cash $266.6M (cash $270.9M − debt $4.3M) = 56.1% of market cap $475.6M

Related tickers

ALIT

Alight, Inc. / Delaware

GANX

GAIN THERAPEUTICS, INC

PLRX

PLIANT THERAPEUTICS, INC.